Skip Navigation LinksHome > January 2009 - Volume 110 - Issue 1 > Expression Profile of Nerve Growth Factor after Muscle Incis...
Anesthesiology:
doi: 10.1097/ALN.0b013e318190bc84
Pain Medicine

Expression Profile of Nerve Growth Factor after Muscle Incision in the Rat

Wu, Chaoran M.D., Ph.D.*; Erickson, Mark A. B.S.†; Xu, Jun M.D.‡; Wild, Kenneth D. Ph.D.§; Brennan, Timothy J. M.D., Ph.D.∥

Free Access
Article Outline
Collapse Box

Author Information

Collapse Box

Abstract

Background: Previous studies have demonstrated that nerve growth factor (NGF) is an important mediator of pathologic pain. Many studies have focused on cutaneous mechanisms for NGF-induced hyperalgesia; few have examined its contribution in deeper tissues like muscle. This study examined pain behaviors and the expression of NGF in incised hind paw flexor digitorum brevis muscle.
Methods: Adult Sprague-Dawley rats were pretreated with anti-NGF peptibody and underwent skin or skin plus deep fascia and muscle incision. Guarding pain behaviors were measured. Muscle NGF messenger RNA (mRNA) was measured by reverse-transcriptase polymerase chain reaction. Changes in NGF protein expression were measured using Western blot, enzyme-linked immunosorbent assay, and immunohistochemistry. In situ hybridization for NGF mRNA was also performed.
Results: Pretreatment with anti-NGF peptibody (100 mg/kg) decreased the guarding behavior caused by deep fascia and muscle incision. Muscle NGF mRNA increased abruptly 2 h after incision and was the same as control by postoperative day 1. NGF protein increased from 4 h after incision and was sustained for several days. NGF was localized in many calcitonin gene-related peptide-positive axons, few N52-positive axons, but not isolectin B4-positive axons in incised muscle. The sources of NGF mRNA included keratinocytes in epidermis and fibroblasts in deeper tissues.
Conclusion: Fibroblasts adjacent to the injury are sources of NGF in incised muscle. NGF is upregulated by incision of muscle and contributes to guarding pain behavior.
NERVE growth factor (NGF) promotes survival of nociceptors and the sympathetic nervous system during late embryonic development.1 In the adult, NGF is essential for the sprouting of nerve fibers and induction of inflammatory pain; from this, NGF has garnered considerable interest in pain research.2
Administration of exogenous NGF has been shown to produce hyperalgesia in rats3 and humans,4,5 and neutralization of NGF by trkA-IgG fusion molecule prevents the sensitization of nociceptors in some pain models.6 The most direct evidence for sensitization of cutaneous afferents by NGF was demonstrated in electrophysiological recordings of nociceptors using the in vitro skin-nerve preparation.7 Application of NGF to the receptive fields of cutaneous C-mechanoheat nociceptors resulted in sensitization to noxious heat.
Interest in postoperative pain management has prompted further investigation for novel therapies that will facilitate better pain control and limit side effects. NGF is one mediator that likely contributes to nociceptor sensitization, hyperalgesia, and clinical pain after surgery.8 Previous studies on skin demonstrated upregulation of NGF mRNA immediately after skin incision; increased NGF protein is sustained for several days.9 The increase in NGF occurs at times that are coincident with its role in pain-related behaviors,10 indicating a relationship between NGF, cutaneous incision, and pain.
In contrast to skin, deep tissue like muscle also contributes to postoperative pain. For example, after abdominal surgery, patients have pain with deep breathing, during cough and with rising from a supine position. Muscle pain is often dull and aching, and difficult to localize. Indeed, muscle afferents form fewer synapses on spinal cord neurons than cutaneous afferents, and descending inhibition of nociceptive spinal cord neurons is stronger for muscle input than for cutaneous input, suggesting different nociceptive processes from muscle compared to skin.11 Muscle incisional pain is likely unique and different than pain from skin incision. Nothing is known about the expression pattern of NGF in incised muscle.
In this study, we compared the effect of NGF blockade on pain-related behaviors after skin incision and after skin and deep incision of the hind paw fascia and flexor digitorum brevis muscle. NGF expression in the hind paw flexor digitorum brevis muscle after plantar incision was measured using quantitative reverse transcriptase–polymerase chain reaction (RT-PCR), in situ hybridization, enzyme-linked immunosorbent assay, Western blot, and immunohistochemistry. The source of NGF mRNA in normal and incised muscle, changes in NGF protein and mRNA at different times after muscle incision, and distribution of muscle NGF immunoreactivity after incision were determined.
Back to Top | Article Outline

Materials and Methods

This study was approved by the institutional Animal Care and Use Committee at the University of Iowa (Iowa City, Iowa). Adult male Sprague-Dawley rats, 225–275 g, were used for all the experiments. Postoperatively, the rats were housed in groups of two or three in clear plastic cages with food and water available ad libitum.
Back to Top | Article Outline
Incision, Anti-NGF Peptibody, and Guarding Pain Scores
Rats were acclimated to the testing environment. After acclimation, 100 mg/kg anti-NGF peptibody12 or vehicle was administered subcutaneously at the neck. The next day, the baseline pain score was measured and the rat underwent plantar incision.13 Under isoflurane anesthesia (1.5–2.0%) and using aseptic conditions, a 1-cm longitudinal incision was made 0.5 cm from the heel on the plantar aspect of the right hind paw. The underlying flexor muscle was dissected and longitudinally incised, and the wound was closed with 5-0 nylon suture. Immediately after surgery, antibiotic ointment was applied to the incision. Sutures were removed on postoperative day (POD) 2. A separate group of rats underwent incision of skin only; no fascia or muscle was incised.
A cumulative pain score was used to assess nonevoked pain behaviors as described previously.14 Unrestrained rats were placed on a plastic mesh floor (8 × 8 mm). The incised and nonincised paws were viewed. Both paws of each animal were closely observed during a 1-min period repeated every 5 min for 1 h. Depending on the position in which each paw was found during the majority of the 1-min scoring period, a 0, 1, or 2 is given. Full weight-bearing of the paw (score = 0) was present if the wound was blanched or distorted by the mesh. If the paw was completely off the mesh, a score of 2 was recorded. If the area of the wound touched the mesh gently without any blanching or distorting, a 1 was given. The sum of the 12 scores (0–24) obtained during the 1-h session for each paw was obtained. The difference between the scores from the incised paw and nonincised paw is the cumulative pain score for that 1 h period. The person performing the behavioral experiments was blinded to the type of incision and the drug (or vehicle) administered.
Back to Top | Article Outline
Quantitative RT-PCR Analysis
Total ribonucleic acid (RNA) from incised rat flexor digitorum brevis muscle tissue was prepared according to manufacturer's instructions using the RNeasy mini kit (Qiagen, Valencia, CA). Some muscle samples from sham-incised rats were used as control. The RNA was quantified using Ribogreen reagent (Molecular Probes, Eugene, OR). Two-step RT-PCR was performed on the 7000 Sequence Detection System (Applied Biosystems, Foster City, CA) by using the TaqMan Gold RT-PCR kit (Applied Biosystems). The RNA was reverse transcribed using random hexamers, and the complementary deoxyribonucleic acid (cDNA) was amplified using a primer/ probe set specific for NGF (RatNGF-fwd: TGACTCCAAGCACTGGAACTCAT, complementary to 693–715 nucleotides in the rat NGF mRNA; RatNGF-rev: GTTTGTCGTCTGTTGTCAACGC, complementary to 947–926 nucleotides in the rat NGF mRNA; RatNGF-Tamra: TGCACCACGACTCACACCTTTGTCA, complementary to 718–742 nucleotides in the rat NGF mRNA). The resulting PCR product was 309 bp in length. Thermal cycling was initiated with an initial incubation at 95°C for 10 min. After that, 40 PCR cycles were performed; each cycle consisted of heating at 95°C for 15 s for melting and at 60°C for 1 min for annealing and extension. The samples were analyzed in triplicate from the reverse-transcription step and normalized to the internal control, a housekeeping gene, β-actin. No template samples were used as controls. PCR data were analyzed by the ΔΔCt method described in detail by Livak et al.15
Back to Top | Article Outline
Enzyme-linked Immunosorbent Assay
Flexor digitorum brevis muscle samples were taken from control rats and injured rats at 4 h, and 1, 2, 5, and 10 days after plantar incision. Muscle tissue from origin to insertion was harvested from each animal after they were euthanized with carbon dioxide. Immediately after extraction, the tissue samples were homogenized and lysed in ice-cold radioimmunoprecipitation assay buffer containing protease inhibitors. The homogenates were centrifuged, and the supernatant was taken. Total protein concentration in each sample was determined using a modified Lowry protein assay. The NGF concentration was measured using a commercially available assay per manufacturer's instructions (NGF Emax Immunoassay; Promega, Madison, WI). This assay exhibits very low crossreactivity with structurally related growth factors, and a minimum of 7.8 pg/ml NGF can be quantified.
Back to Top | Article Outline
Western Blot Analysis
After assay of total protein, 20 μg of protein in 20 μl of volume from each sample was electrophoresed on 12% sodium dodecyl sulfate-polyacrylaminde gels and then transferred to polyvinylidene difluoride membranes (Bio-Rad Lab, Hercules, CA). Overnight incubation of the membranes in rabbit anti-NGF polyclonal antibody (1:1000, Cat # sc-548; Santa Cruz Biotechnology Inc., Santa Cruz, CA) at 4°C was followed by incubation in peroxidase-conjugated donkey anti-rabbit IgG secondary antibody (1:10,000; Jackson ImmunoRes, West Grove, PA) for 4 h. Membranes were then developed with SuperSignal West Femto Maximum Sensitivity Substrate (Pierce Biotechnology Inc., Rockford, IL) and scanned by Kodak Image Station 440 scanner (Eastman Kodak Company, Rochester, NY). After the membranes were scanned, they were incubated in stripping buffer at 50°C for 30 min and probed for actin as a loading control. Immunoreactive NGF band intensity was quantified and normalized with actin bands by Image J software (NIH, Bethesda, MD). In a previous study, we demonstrated that the antibody was immunoreactive to mature rat NGF (N2513; Sigma, St. Louis, MO); no immunoreactive bands were noted when we added the blocking hapten peptide (cat. No. sc-548 P; Santa Cruz Biotechnology Inc.) containing the antigen (100 μg/0.5 ml) used to raise the antibody.9
Back to Top | Article Outline
Immunohistochemistry
Briefly, rats were anesthetized with sodium pentobarbital (150 mg/kg) and transcardiacally perfused with 0.1 m phosphate-buffered saline followed by 4% paraformaldehyde. The glabrous plantar skin samples together with deep tissue and flexor muscle were removed from sham and incised hindpaws and postfixed in the same fixative for 4 h. After washing in gradually increasing concentrations of sucrose, samples were rapidly frozen in 2-methylbutane chilled at –80°C. Consecutive sections (10 μm) were prepared and frozen at –80°C until usage. NGF expression was visualized by NGF immunohistochemisty using the ABC method. The following antibodies were used: rabbit anti-NGF antibody (1:2000, Cat # sc-548; Santa Cruz Biotechnology Inc.) and biotinylated anti-rabbit IgG (1:500; Vector Laboratories, Burlingame, CA). For controls, some sections were processed after preabsorption of the anti-NGF antibody with the blocking peptide (4 pg/μl). Other sections were processed without the primary or the secondary antibody as controls.
Back to Top | Article Outline
Immunofluorescence
Double-labeling confocal microscopy and immunofluorescent staining were performed for NGF and protein gene product 9.5 (PGP 9.5, a panaxonal marker), calcitonin gene-related peptide (CGRP, a peptidergic C-fiber marker), isolectin B4 (IB4, a nonpeptidergic C-fiber marker), or neurofilament 200 (N52, a myelinated A-fiber marker) to examine the colocalization of NGF and sensory fibers. To block nonspecific reactions, sections were incubated in 0.1 m phosphate-buffered saline containing 1.5% bovine serum albumin and 0.1% Tween-20 for 1 h. Sections were processed for NGF and PGP 9.5, CGRP, IB4, or N52 double-labeling. The following primary antibodies were used: rabbit anti-NGF polyclonal antibody (1:1000, Cat # sc-548; Santa Cruz Biotechnology Inc), guinea pig anti-PGP 9.5 polyclonal antibody (1:1000, Cat # AB5898; Chemicon, Temecula, CA), rabbit anti-CGRP polyclonal antibody (1:1000, Cat # T-4032; Peninsula Laboratories Inc, San Carlos, CA), biotinylated griffonia simplicifolia lectin I (IB4, 1:8000, Cat # B-1105; Vector Laboratories), mouse antineurofilament 200 monoclonal antibody (1:1000, Cat # N0142; Sigma). Sections were then incubated in the following secondary antibodies, Cy3-conjugated goat anti-rabbit IgG, Cy2-conjugated donkey anti-guinea pig IgG, Cy2-conjugated donkey anti-rabbit IgG, Cy2-conjugated streptavidin and Cy2-conjugated goat antimouse IgG. All the secondary antibodies were obtained from Jackson ImmunoResearch (West Grove, PA) and applied to sections with a concentration of 1:200. Sections were mounted and observed under Zeiss 510 confocal microscopy (Carl Zeiss MicroImaging, Inc., Thornwood, NY). Digital images were collected in the LSM 510 software (Carl Zeiss MicroImaging, Inc). For controls, sections were stained without primary or secondary antibodies.
Back to Top | Article Outline
In Situ Hybridization
Rat hind paw flexor digitorum brevis muscle was taken 1 h after incision. Total RNA was isolated using RNeasy mini kit (Qiagen). One microgram of RNA was used for RT-PCR to amplify a 416-bp band of NGF using primers: forward, 5′-CCATGGTACAATCTCCTTCA-3′; reverse, 5′:-TGCAGGCAAGTCAGCCTCTT-3′. The product was purified using QIAquick PCR purification kit (Qiagen) and then subcloned into T-easy vector (Promega). After sequencing, the template was linearized with Sal I digestion and gel purified using QIAquick Gel Extraction kit (Qiagen). Digoxigenin-labeled probes were made using DIG RNA Labeling Kit (Roche, Mannheim, Germany), and the labeling efficiency was quantified using DIG Luminescent Detection Kit (Roche). All procedures were performed following the manufacturers' instruction.
Sections were postfixed in 4% paraformaldehyde for 10 min and permeabilized by treatment with 0.002% proteinase K for 5 min. Fixation in 4% paraformaldehyde again for 5 min and underwent acetylation (0.5% acetic anhydride in 0.1 m triethanolamine) for 10 min. Probes were diluted to 10 ng/ml in hybridization buffer (50% formamide, 4 × standard saline citrate, 0.5 × Denhardt solution, 0.025% yeast tRNA, 0.025% PolyA, 0.025% salmon sperm DNA, 20% dextran sulfate, and 0.1 m dithiothreitol). The sections were hybridized in a humidified chamber at 55°C overnight with sense, antisense or internal control (actin) probes. Some sections were also incubated in a hybridization solution containing no probe. Adult rat cortex sections were hybridized with NGF sense or antisense probes as positive control because it is well accepted that NGF is produced by neurons in cortex.
After hybridization, sections were subjected to post-hybridization washes to remove unbound probes. Endogenous alkaline phosphatase was blocked with blocking reagent (Roche) dissolved in 1 × MABT (0.88% NaCl, 1.16% maleic acid, 0.72% NaOH) containing 0.01% Tween-20 and 20% goat serum for 60 min. Signal was detected by incubating sections with sheep antidigoxigenin-AP, Fab fragments antibody (1:2000, Cat# 11093274910; Roche) at 4°C overnight, visualized with alkaline phosphatase color substrates, nitroblue tetrazolium/5-Bromo-4-Chloro-Indolyl-Phosphatase for 2 h. The color reaction was stopped by immersing sections in 0.1 m phosphate-buffered saline. Sections were then counterstained in nuclear fast red for 1 min, dehydrated, and mounted for microscopic examination.
Back to Top | Article Outline
Statistical Analyses
All statistical analyses were performed using Prism 4.0 (GraphPad Software, Inc., San Diego, CA). Data were expressed as mean ± SEM. Differences between means were determined by 1-way ANOVA followed by Dunnett post hoc test for comparisons of incision versus sham. Guarding pain scores were analyzed by ANOVA. Subsequent 1-way ANOVA for repeated measures and post hoc t tests compared the effect of drug and Dunnett test versus baseline examined the effect of incision. P < 0.05 was considered statistically significant.
Back to Top | Article Outline

Results

Anti-NGF and Guarding Behavior
Fig. 1
Fig. 1
Image Tools
Incision of skin and treatment with vehicle resulted in a cumulative pain score of 4.3 ± 1.3 (fig. 1A; P < 0.05 vs. baseline) 4 h after incision. There was no significant guarding thereafter. Treatment with the anti-NGF peptibody (100 mg/kg) and skin incision were not different than vehicle and skin incision.
In rats that underwent incision of skin, fascia, and muscle and were treated with vehicle, guarding was increased at 4 h, 1 day, and 2 days to 11.9 ± 0.6, 8.8 ± 1.2, 5.0 ± 0.7, respectively (fig. 1B; P < 0.05 vs. baseline). Guarding after pretreatment with anti-NGF peptibody (100 mg/kg) and skin, fascia, and muscle incision was 8.1 ± 1.4, 4.6 ± 0.7, 2.1 ± 0.5, at 4 h, 1 day, and 2 days, respectively. The anti-NGF peptibody decreased guarding by skin fascia and muscle incision at 4 h, 1 day, and 2 days (P < 0.05 vs. vehicle).
Back to Top | Article Outline
RT-PCR Of mRNA Levels for NGF in Incised Hind Paw Muscle
Fig. 2
Fig. 2
Image Tools
Compared to the β-actin control, NGF mRNA increased 6.6 ± 1.3-fold (P < 0.01 vs. sham) in incised flexor muscle at 2 h after incision compared with sham control skin (fig. 2A; n = 6 per group). The level of NGF mRNA was not significantly increased on POD 1 and thereafter and was similar to the contralateral, nonincised hind paw flexor muscle.
Back to Top | Article Outline
NGF Protein Expression in Incised Hind Paw Muscle
As shown in figure 2B, basal NGF expression was 149.3 ± 35.9 ng/mg protein in sham-operated muscle. NGF levels increased to 614.3 ± 61.3 ng/mg (P < 0.01 vs. sham) by 4 h and peaked at 923.4 ± 101.3 ng/mg on POD 1 in incised muscle. After POD 1, levels of NGF expression were 803.3 ± 47.3 ng/mg, and 725.1 ± 135.5 ng/mg on POD 2 (P < 0.01 vs. sham, n = 6 per group), and POD 5 (P < 0.01 vs. sham, n = 6 per group), respectively. NGF was not different than control on POD 10 (449.8 ± 131.6 ng/mg) and at the contralateral hind paw muscle (100.1 ± 35.1 ng/mg).
Western blot analysis revealed a single high–molecular weight (MW) NGF increased by incision. Representative blots were shown in figure 2C top. This large MW form of NGF protein, approximately 75 kDa, was increased in incised muscle. A summary quantifying the NGF immunoreactive bands for different times after incision is shown in figure 2C bottom. The data were normalized to actin (n = 6 per group). In comparison to sham, NGF expression in the incised hind paw increased initially 2.4 ± 0.4-fold by 4 h to 7.8 ± 2.6-fold (P < 0.01 vs. sham) on POD 1. Intensity of NGF expression was increased 7.0 ± 1.9-fold (P < 0.05 vs. sham) on POD 2, 4.5 ± 1.3-fold on POD 5, and 3.1 ± 0.5-fold POD 10. NGF expression in the contralateral, unincised hind paw flexor muscle (1.0 ± 0.4-fold) was the same as sham.
Back to Top | Article Outline
Immunohistochemistry of Incised Hind Paw Muscle for NGF
Fig. 3
Fig. 3
Image Tools
There was no NGF immunoreactivity detected in sham-operated, control flexor muscle (fig. 3A). NGF immunoreactivity was found in apparent nerve-like structures in incised muscle on POD 1 (fig. 3B). Higher magnifications of the rectangular areas marked in figure 3B are shown in figure 3C and 3D. NGF immunoreactive elements were localized within transverse and longitudinal sections of nerve-like structures (fig. 3, C and D). After preabsorption of the anti-NGF antibody with the hapten-blocking peptide, there was no NGF immunoreactivity detected in skin, fascia, and muscle (fig. 3E).
Back to Top | Article Outline
Immunofluorescent Double-Labeling For NGF In Incised Hind Paw Muscle
Fig. 4
Fig. 4
Image Tools
Fig. 5
Fig. 5
Image Tools
NGF and PGP 9.5, CGRP, or IB4 double-labeling was performed to confirm the immunoreactive NGF in nerve structures. NGF-positive staining was found in nerve axons labeled with PGP 9.5 in incised muscle 1 day after incision (fig. 4, A–A2). These NGF-positive axons were colocalized with CGRP-positive fibers (fig. 4, B–B2), but not IB4-positive non-peptidergic C-fibers (fig. 4, C–C2). NGF-positive staining could also be found in large nerve bundles in deep tissue, which innervates the flexor digitorum brevis muscle (fig. 5) and possibly other deep structures. In these bundles, NGF immunoreactivity was colocalized with CGRP-positive fibers (fig. 5, A–A2). There was no colabeling of NGF with IB4-positive C-fibers (fig. 5, B–B2), but colabeling was present on some N52-labeled myelinated axons (fig. 5, C–C2).
Back to Top | Article Outline
In Situ Hybridization For NGF mRNA Expression in Incised Hind Paw
Fig. 6
Fig. 6
Image Tools
Adult rat brain cortex sections were subjected to in situ hybridization with NGF antisense and sense probes to examine the specificity of the NGF probes (fig. 6). NGF mRNA signals (blue) could be observed in cortex (fig. 6A) by antisense probe hybridization, and most of the signals were localized in cytoplasm surrounding the nucleus (red) of neurons (fig. 6B). There was no NGF mRNA staining in cortex when hybridized with the sense probe (fig. 6C); only nuclear staining (red) was observed (fig. 6D).
Fig. 7
Fig. 7
Image Tools
NGF mRNA expression could be found in sections obtained from sham-incised hind paw (fig. 7A). The sources of NGF mRNA included keratinocytes in the epidermis and fibroblasts in dermis (fig. 7B). In deeper tissue, fibroblasts in dense connective tissue (fig. 7C), perimysium of muscle (fig. 7D), perivascular connective tissue (fig. 7E), and a large nerve bundle (fig. 7F) innervating the muscle were positive for NGF mRNA.
Fig. 8
Fig. 8
Image Tools
NGF mRNA labeling was observed in sections obtained at 2 h after plantar incision (fig. 8A) when NGF mRNA by RT-PCR was increased. In addition to structures labeled in the unincised tissue (fig. 8, B–F), fibroblasts in the subcutaneous region adjacent to the dissected tissue and the incision (fig. 8G) and fibroblasts adjacent to the muscle incision (fig. 8H) produced NGF mRNA. In situ hybridization with NGF sense probe at 2 h after incision did not show NGF mRNA–positive signals (fig. 8I).
Back to Top | Article Outline

Discussion

In this study, incision that included hind paw fascia and flexor digitorum brevis muscle produced guarding behavior that was reduced by blockade of NGF. NGF expression was examined in normal and in incised hind paw muscle. NGF mRNA was increased at 2 h after incision and returned to normal on POD 1. NGF protein increased 4 h after muscle incision, was increased for 5 days, and was not different than control on POD 10. A large MW form of NGF was produced and increased by incision. NGF immunoreactivity was not identified in normal muscle; however, NGF-immunoreactive structures were observed in nerve bundles from incised muscle. Further delineation of the immunoreactive structures revealed that NGF staining was present in CGRP- and N52-positive axons. IB4-positive axons did not stain for NGF. NGF mRNA was present in normal hind paw sections. Fibroblasts were the sources of NGF mRNA in perimysium, perivascular connective tissue, and nerve adjacent to the incised muscle.
NGF is an important pain mediator in skin,2 but NGF and muscle have been studied to a lesser extent. NGF is synthesized in normal skeletal muscle tissue, but the cellular elements producing NGF are not known.16,17 Studies by others indicate that NGF contributes to muscle healing after injury.18 NGF is also upregulated in muscle after intramuscular formalin injection.19
Previously conducted human studies indicate the potential role of NGF in muscle pain. Local injection of NGF into the masseter muscle produces long-term local signs of mechanical allodynia and hyperalgesia and is associated with pain during jaw movement.20 In trials of parenterally administered NGF for patients with diabetic neuropathy, NGF did not improve symptoms. Rather, administration of NGF elicited whole-body myalgias in patients.4 The duration and severity of these myalgias were dose-dependent.
Muscle nerves contain motor axons, sensory axons, and sympathetic axons; the sensory fibers are both myelinated and unmyelinated.21 Our data have shown immunocytochemical labeling for NGF in CGRP-positive peptidergic axons that may also express the high-affinity NGF receptor trkA.22–24 NGF labeling was not found in IB4-positive nonpeptidergic axons. In incisions, NGF was colabeled with the myelinated axon marker N52-positive in a few fibers. There is approximately 10% overlap between CGRP- and N52-positive axons; therefore, these NGF-positive, N52-positive fibers may also have the trkA receptor.25 In animal studies, intramuscular injection of NGF excites primary afferent muscle nociceptors26 and dorsal horn neurons transmitting nociception from muscle.27,28 One study was not able to detect sensitization of nociceptors by NGF injected into rat masseter muscle.29 Muscle afferents transmit both mechanosensitivity and chemosensitivity.30–33 There is also evidence that muscle afferents have thermosensitivity.34
NGF released by muscle incision likely influences the sensitivity of nociceptors to a variety of mediators, although no systematic studies of NGF and muscle sensory ion channels and receptors have been described. In other tissues, NGF regulates a number of ligand-gated ion channels, including purinergic receptor of ATP (P2X3), acid-sensing ion channel 3, transient receptor potential vanilloid 1, and G protein–coupled receptors, including bradykinin B2 receptors.35 NGF also increases voltage-gated sodium channels, including tetradodotoxin-sensitive and tetradodotoxin-resistant sodium channels (Nav 1.3, 1.8, and 1.9). Whether these mechanisms through which NGF contributes to nociception in other tissues also influence nociception from muscle is not known. We speculate that NGF influences chemosensitivity of muscle afferents after incision, potentiating its responses to mediators like prostaglandins, acid, and lactate.
NGF is produced in several forms by a variety of tissues and cells depending on the conditions. A large MW form of NGF, approximately 75 kDa, was shown after muscle incision in the current study and after skin incision in a previous study.9 Mature NGF is approximately 16 kDa; therefore, this large MW form is likely a glycosylated precursor, like preproNGF, or a dimer of a precursor form.36,37 Isaacson et al.37,38 demonstrated that mature forms of the lower MW NGF proteins are uncommon in tissues, and each tissue exhibits a characteristic NGF expression pattern. In adults, muscle and skin have the same large MW form, and both increase in response to incision.
In vitro studies of primary cell cultures indicate that NGF is produced by fibroblasts,39 keratinocytes,40 and T cells.41 In inflammatory pain models, NGF is likely produced by macrophages42 and mast cells43; after nerve injury, Schwann cells are a source of NGF.44
In the current study, NGF mRNA was identified using in situ hybridization in normal plantar skin and flexor muscle as well as in incised tissue. Fibroblasts from fascia and connective tissues surrounding muscle express NGF in the area injured by the incision. NGF mRNA was found in nonneuronal cells, whereas NGF protein was localized in nerve fibers. NGF expression by inflammatory cells was not prominent. The different NGF source in our incisional pain model compared with other inflammatory pain models supports the unique characteristics for incisional pain mechanisms versus inflammatory pain. Our data are supported by another study of cutaneous wound healing,45 which demonstrates that NGF is produced by keratinocytes and fibroblasts and contributes to cutaneous wound healing.
In previously performed studies in skin,9 we demonstrated that NGF protein is present in the area surrounding incised skin. In transverse hind paw skin incisions, immunoreactive NGF was prominent in distal axons in skin but not found in axons proximal to the incision. On the basis of these previous results, the current study, and work by others,46,47 we propose the following model. NGF is synthesized in fibroblasts and connective tissue in incisions, is retrogradely transported to the dorsal root ganglia in intact axons, and sensitizes these nociceptors. The distal portions of cut axons take up NGF but do not transport it retrogradely.46 These distal portions of the cut axons are immunoreactive for NGF. The colabeling of NGF with CGRP indicates that these are Trk A–positive axons. In incised skin, NGF produces heat sensitization.10 In deep muscle incision, we propose that NGF produces spontaneous activity resulting in ongoing pain.
In summary, NGF contributes to guarding pain behaviors caused by deep muscle incision. In incised muscle, NGF mRNA increases 2 h after incision, and increased protein expression is evident for several days. Immunohistochemical studies of incisions reveals NGF protein in CGRP-positive but not IB4-positive nerve fibers. Fibroblasts adjacent to the injury are sources of NGF in incised muscle. NGF is not only important for cutaneous pain mechanism but also for pain from incised muscle.
The authors thank Alberto Subieta, B.S., Research Assistant, Department of Anesthesia, University of Iowa, Iowa City, Iowa, for technical assistance.
Back to Top | Article Outline

References

1. Levi-Montalcini R, Dal Toso R, della Valle F, Skaper SD, Leon A: Update of the NGF saga. J Neurol Sci 1995; 130:119–27

2. Julius D, Basbaum AI: Molecular mechanisms of nociception. Nature 2001; 413:203–10

3. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J: Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994; 62:327–31

4. Petty BG, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, Wachsman M, Sinicropi D, Burton LE, Peroutka SJ: The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 1994; 36:244–6

5. Dyck PJ, Peroutka S, Rask C, Burton E, Baker MK, Lehman KA, Gillen DA, Hokanson JL, O'Brien PC: Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 1997; 48:501–5

6. McMahon SB, Bennett DL, Priestley JV, Shelton DL: The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat Med 1995; 1:774–80

7. Rueff A, Mendell LM: Nerve growth factor NT-5 induce increased thermal sensitivity of cutaneous nociceptors in vitro. J Neurophysiol 1996; 76:3593–6

8. Zahn PK, Subieta A, Park SS, Brennan TJ: Effect of blockade of nerve growth factor and tumor necrosis factor on pain behaviors after plantar incision. J Pain 2004; 5:157–63

9. Wu C, Boustany L, Liang H, Brennan TJ: Nerve growth factor expression after plantar incision in the rat. Anesthesiology 2007; 107:128–35

10. Banik RK, Subieta AR, Wu C, Brennan TJ: Increased nerve growth factor after rat plantar incision contributes to guarding behavior and heat hyperalgesia. Pain 2005; 117:68–76

11. Schaible H-G: Basic mechanisms of deep somatic pain, Textbook of Pain, 5th edition. Edited by McMahon SB, Koltzenburg M. Philadelphia, Elsevier, 2006, pp 621–33

12. Wild KD, Bian D, Zhu D, Davis J, Bannon AW, Zhang TJ, Louis JC: Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance. J Pharmacol Exp Ther 2007; 322:282–7

13. Brennan TJ, Vandermeulen EP, Gebhart GF: Characterization of a rat model of incisional pain. Pain 1996; 64:493–501

14. Zahn PK, Gysbers D, Brennan TJ: Effect of systemic and intrathecal morphine in a rat model of postoperative pain. Anesthesiology 1997; 86:1066–77

15. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25:402–8

16. Amano T, Yamakuni T, Okabe N, Sakimura K, Takahashi Y: Production of nerve growth factor in rat skeletal muscle. Neurosci Lett 1991; 132:5–7

17. Stuerenburg HJ, Kunze K: Tissue concentrations of nerve growth factor in aging rat heart and skeletal muscle. Muscle Nerve 1998; 21:404–6

18. Menetrey J, Kasemkijwattana C, Day CS, Bosch P, Vogt M, Fu FH, Moreland MS, Huard J: Growth factors improve muscle healing in vivo. J Bone Joint Surg Br 2000; 82:131–7

19. Schafers M, Sorkin LS, Sommer C: Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain 2003; 104:579–88

20. Svensson P, Cairns BE, Wang K, Arendt-Nielsen L: Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain 2003; 104:241–7

21. Mense S: Nociception from skeletal muscle in relation to clinical muscle pain. Pain 1993; 54:241–89

22. Averill S, McMahon SB, Clary DO, Reichardt LF, Priestley JV: Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons. Eur J Neurosci 1995; 7:1484–94

23. Bennett DL, Dmietrieva N, Priestley JV, Clary D, McMahon SB: trkA, CGRP and IB4 expression in retrogradely labelled cutaneous and visceral primary sensory neurones in the rat. Neurosci Lett 1996; 206:33–6

24. McMahon SB, Armanini MP, Ling LH, Phillips HS: Expression and coexpression of Trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 1994; 12:1161–71

25. Meyer RA, Ringkamp M, Campbell JN, Raja SN: Peripherial mechanisms of cutaneous nociception, Textbook of Pain, 5th edition, Edited by McMahon SB, Koltzenburg M. Philadelphia, Elsevier, 2006, pp 3–34

26. Hoheisel U, Unger T, Mense S: Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the rat. Pain 2005; 114:168–76

27. Taguchi T, Hoheisel U, Mense S: Dorsal horn neurons having input from low back structures in rats. Pain 2008; 138:119–29

28. Hoheisel U, Unger T, Mense S: Sensitization of rat dorsal horn neurons by NGF-induced subthreshold potentials and low-frequency activation. A study employing intracellular recordings in vivo. Brain Res 2007; 1169:34–43

29. Mann MK, Dong XD, Svensson P, Cairns BE: Influence of intramuscular nerve growth factor injection on the response properties of rat masseter muscle afferent fibers. J Orofac Pain 2006; 20:325–36

30. Kumazawa T, Mizumura K: Thin-fibre receptors responding to mechanical, chemical, and thermal stimulation in the skeletal muscle of the dog. J Physiol 1977; 273:179–94

31. Mense S, Meyer H: Different types of slowly conducting afferent units in cat skeletal muscle and tendon. J Physiol 1985; 363:403–17

32. Paintal AS: Functional analysis of group III afferent fibres of mammalian muscles. J Physiol 1960; 152:250–70

33. Kaufman MP, Iwamoto GA, Longhurst JC, Mitchell JH: Effects of capsaicin and bradykinin on afferent fibers with ending in skeletal muscle. Circ Res 1982; 50:133–9

34. Graven-Nielsen T, Arendt-Nielsen L, Mense S: Thermosensitivity of muscle: high-intensity thermal stimulation of muscle tissue induces muscle pain in humans. J Physiol 2002; 540:647–56

35. Pezet S, McMahon SB: Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 2006; 29:507–38

36. Yardley G, Relf B, Lakshmanan J, Reinshagen M, Moore GP: Expression of nerve growth factor mRNA and its translation products in the anagen hair follicle. Exp Dermatol 2000; 9:283–9

37. Bierl MA, Jones EE, Crutcher KA, Isaacson LG: 'Mature' nerve growth factor is a minor species in most peripheral tissues. Neurosci Lett 2005; 380:133–7

38. Bierl MA, Isaacson LG: Increased NGF proforms in aged sympathetic neurons and their targets. Neurobiol Aging 2007; 28:122–34

39. Matsuda H, Kannan Y, Ushio H, Kiso Y, Kanemoto T, Suzuki H, Kitamura Y: Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med 1991; 174:7–14

40. Tron VA, Coughlin MD, Jang DE, Stanisz J, Sauder DN: Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest 1990; 85:1085–9

41. Ehrhard PB, Erb P, Graumann U, Otten U: Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci U S A 1993; 90:10984–8

42. Lindholm D, Heumann R, Meyer M, Thoenen H: Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987; 330:658–9

43. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, Levi-Montalcini R: Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A 1994; 91:3739–43

44. Johnson EM Taniuchi M, DiStefano PS: Expression and possible function of nerve growth factor receptors on Schwann cells. Trends Neurosci 1988; 11:299–304

45. Matsuda H, Koyama H, Sato H, Sawada J, Itakura A, Tanaka A, Matsumoto M, Konno K, Ushio H, Matsuda K: Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J Exp Med 1998; 187:297–306

46. Raivich G, Hellweg R, Kreutzberg GW: NGF receptor-mediated reduction in axonal NGF uptake and retrograde transport following sciatic nerve injury and during regeneration. Neuron 1991; 7:151–64

47. Curtis R, Tonra JR, Stark JL, Adryan KM, Park JS, Cliffer KD, Lindsay RM, DiStefano PS: Neuronal injury increases retrograde axonal transport of the neurotrophins to spinal sensory neurons and motor neurons via multiple receptor mechanisms. Mol Cell Neurosci 1998; 12:105–18

Cited By:

This article has been cited 6 time(s).

Journal of Musculoskeletal & Neuronal Interactions
Pressure pain perception at the injured foot: the impact of diabetic neuropathy
Wienemann, T; Chantelau, EA; Richter, A
Journal of Musculoskeletal & Neuronal Interactions, 12(4): 254-261.

Neuroscience
Activation of P38 Mitogen-Activated Protein Kinase in the Dorsal Root Ganglion Contributes to Pain Hypersensitivity After Plantar Incision
Mizukoshi, K; Sasaki, M; Izumi, Y; Miura, M; Watanabe, M; Amaya, F
Neuroscience, 234(): 77-87.
10.1016/j.neuroscience.2013.01.001
CrossRef
Journal of Pharmacological Sciences
Local Administration of a Synthetic Cell-Penetrating Peptide Antagonizing TrkA Function Suppresses Inflammatory Pain in Rats
Ueda, K; Hirose, M; Murata, E; Takatori, M; Ueda, M; Ikeda, H; Shigemi, K
Journal of Pharmacological Sciences, 112(4): 438-443.
10.1254/jphs.09307FP
CrossRef
Pain
Injection of nerve growth factor into a low back muscle induces long-lasting latent hypersensitivity in rat dorsal horn neurons
Hoheisel, U; Reuter, R; de Freitas, MF; Treede, RD; Mense, S
Pain, 154(): 1953-1960.
10.1016/j.pain.2013.05.006
CrossRef
Wound Repair and Regeneration
Wound hypoxia in deep tissue after incision in rats
Kang, S; Lee, D; Theusch, BE; Arpey, CJ; Brennan, TJ
Wound Repair and Regeneration, 21(5): 730-739.
10.1111/wrr.12081
CrossRef
Anesthesiology
Guarding Pain and Spontaneous Activity of Nociceptors after Skin versus Skin Plus Deep Tissue Incision
Xu, J; Brennan, TJ
Anesthesiology, 112(1): 153-164.
10.1097/ALN.0b013e3181c2952e
PDF (1838) | CrossRef
Back to Top | Article Outline

© 2009 American Society of Anesthesiologists, Inc.

Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.
Login

Article Tools

Images

Share